Researchers from the Pandemic Sciences Institute and the Nuffield Department of Medicine’s Centre for Human Genetics have secured funding for a project which will help assess whether vaccines already or previously licensed against Zaire ebolavirus could offer protection against Bundibugyo ebolavirus. The study is a collaboration with the Centre de Recherche et d’Analyse Biomédicale Guinea (CRAM), WACCREP member research institution…
ABSTRACT rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination. READ MORE

